ENT-007

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameENT-007
Drug Alias NameENT-007
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBiliary Tract NeoplasmsGliomaLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEtern BioPharma (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEtern BioPharma (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsBiliary Tract NeoplasmsGliomaLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A